The evaluation of thermal cisplatin sensitization in normal and XP human cells using mild hyperthermia at 40 and 41°C

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2649-2654

  Raaphorst, G P ^a   Yang, D P ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin; Hyperthermia; XP cells

Indexed keywords

CISPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESPONSE; DRUG SENSITIZATION; EXCISION REPAIR; HEAT TOLERANCE; HEATING; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE; CISPLATIN; COMBINED MODALITY THERAPY; DNA REPAIR; FIBROBLASTS; HUMANS; HYPERTHERMIA, INDUCED; XERODERMA PIGMENTOSUM;

EID: 22944454883     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Piver MS: Ovarian carcinoma, A decade of progress. Cancer 54: 2706-2715, 1984.
2. Canal P: Platinum compounds: pharmacokinetics and pharmacodynamics. In: A Clinician's Guide to Chemotherapy, Pharmacokinetics and Pharmacodynamics. Grochow LB and Ames MM (eds.). Williams and Wilkins, Baltimore pp. 345-373, 1998.
3. Rose P, Bundy BN, Watkins EB, Thigpen JT, Deepe G, Maiman MA et al: Concurrent cisplatin based therapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144-1153, 1999.
4. Keys HM, Bundy BN, Stahman FB, Muderspach LI, Chafe WE, Suggs CL III et al: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154-1161, 1999.
5. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high- risk cervical cancer. N Engl J Med 340: 1137-1143, 1999.
6. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG et al: Characterization of cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47: 414-418, 1987.
7. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338: 1798-1804, 1998.
8. Chougule PB, Suk S, Chu QD, Leone L, Nigro PT, McRae R et al: Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study. Cancer 74: 1927-1932, 1994.
9. Harrison LB, Raben A, Pfister DG, Zelefsky M, Strong E, Shah JP et al: A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumours of the head and neck. Head Neck 20: 497-503, 1998.
10. Dewit L: Combined treatment of radiation and cis- diaminedichloroplatinum((II): a review of experimental and clinical data. Int J Radiat Oncol 13: 403-426, 1987.
11. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H et al: Homologous recombination and nonhomologous end-joining pathways of DNA double- strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17: 5497-5508, 1998.
12. Koberle B, Masters, JRW, Hartley JA and Wood RD: Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 9: 273-276, 1999.
13. Fravel HNA, Rawlings CJ and Roberts JJ: Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luleus. Mutat Res 51: 121-132, 1978.
14. Dijt FJ, Fichinger-Schepman AMJ, Berenda F and Reedijk J: Formation and repair of cisplatin induced adducts to DNA in cultured normal and repair deficient human fibroblasts. Cancer Res 48: 6058-6062, 1988.
15. Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR, Brookman KW, Siciliano MJ, Walter Ca, Fan W, Narayana LS, Zhou ZQ, Adamson AW, Sorensen KJ, Chen DJ, Jones NJ and Thompson LH: XRCC2 and XRCC3 new human Rad 51-family members promote chromosome stability and protect against DNA cross links and other damages. Molecular Cell 1: 783-793, 1998.
16. Raaphorst GP, Leblanc JM, Yang DP and Li LF: Comparison of response to cisplatin radiation and combined treatment in cell lines deficient in recombination repair. Anticancer Res, in press 2004.
17. Raaphorst GP: Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. Int J Radiat Oncol 22: 1035-1041, 1992.
18. Armour EP and Raaphorst GP: Long duration mild hyperthermia in brachytherapy. Int J Hyperthermia 20: 175-189, 2004.
19. Raaphorst GP: Thermal radiosensitization in vitro. In: Hyperthermia and Oncology Volume 2. Urano M, Douple E (eds.). VSP, Utrecht pp. 17-51, 1989.
20. Klein ME, Frayer K and Bachur K: Hyperthermic enhancement of chemotherapeutic agent in L1210 leukemia. Blood 50: 210-133, 1977.
21. Hettinga JVE, Lemstra W, Meijer C et al: Hyperthermic potentiation of cisplatin toxicity in human small cell lung carcinoma cell line and a cisplatin resistant subline. Int J Hypertherm 10: 795-805, 1994.
22. Raaphorst GP, Miao J, Stewart DJ and Ng CE: Concomitant treatment with mild hyperthermia, cisplatin and low dose rate irradiation in human ovarian cells sensitive and resistant to cisplatin. Oncol Rep 5: 971-978, 1998.
23. Kubuta N, Kakehi M and Inada T: Hyperthermia enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. Int J Radiat Oncol 25: 491-497, 1993.
24. Urano M, Kahn J and Kenton LA: The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. Int J Hypertherm 6: 563-570, 1990.
25. Konings AWT, Hettinga JVE, Lemstra W, Humphrey GB and Kapinga HH: Sensitizing for cisplatin action by hyperthermia in resistant cells. Int J Hypertherm 9: 553-562, 1993.
26. Hettinga JVE, Konings AWT and Kampinga HH: Reduction of cellular cisplatin resistance by hyperthermia - a review. Int J Hypertherm 13: 439-457, 1997.
27. Raaphorst GP, Wang G, Stewart D and Ng CE: A study of cisplatin-radiosensitization through inhibition of repair of sublethal radiation damage in ovarian carcinoma cells sensitive and resistant to cisplatin. Int J Oncol 7: 1373-1378, 1995.
28. de Laat WL, Jaspers NGJ and Hoeijmakers JHJ: Molecular mechanisms of nucleotide excision repair. Genes Develop 13: 768-785, 1999.
29. Wong RSL, Dynlacht JR, Cedervall B and Dewey WC: Analysis by pulsed field gel electrophoresis of DNA double strand breaks induced by head and/or irradiation in bulk and replicating DNA of CHO cells. Int J Radiat Biol 68: 141-152, 1995.
30. Dewey WC: Mechanisms of thermal radiosensitization. In: Hyperthermia and Oncology Volume 2. Urano M and Douple E (eds.) VSP Utrecht, pp. 1-16, 1989.
31. Urano M: Thermochemotherapy from in vitro and in vivo experiments to potential clinical application. In: Hyperthermia and Oncology Volume 4. Urano M and Douple E (eds.). VSP Utrecht, pp. 169-204, 1994.
32. Mitchel RE, Smith BP, Wheatly N, Chan A, Child S and Paterson MC: Sensitivity of hyperthermia-treated human cells to killing by ultraviolet or gamma radiation. Rad Res 104: 234-241, 1985.
33. Herman TS, Sweets CC, White DM and Gerner EW: Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Int 68: 487-491, 1982.
34. Ohtsubo T, Chang SW, Tsuji K, Picha P, Saito H and Kano E: Effects of cis- diammedichloroplatinum (CDDP) and cis-diammine (1,1- cyclobutanedicarboxylate) platinum (CBDCA) on thermotolerance development and thermosensitivity of the thermotolerant cells. Int J Hypertherm 6: 1031-1039, 1990.
35. Neilan BA, Henle KJ, Nagle WA and Moss AJ: Cytotoxicity of hyperthermia combined with bleomycin or cisplatinum in cultured RIF cells: modification by thermotolerance polyhydroxy compounds. Cancer Res 46: 2245-2247, 1986.
36. Honess DJ: Interaction between thermochemotherapy and thermotolerance. In: Hyperthermia and Oncology Volume 4. Urano M and Douple E (eds.). VSP Utrecht, pp. 71-89, 1994.